The Trump administration has initiated investigations into the importation of pharmaceuticals and semiconductors, aiming to impose tariffs on these sectors due to national security concerns. Notices released in the Federal Register outline a 21-day public comment period, signaling potential changes in trade policy affecting critical industries.